Health Insurance (1992-1993 Pathology Services Table) Regulations (Cth)

Statutory Rules 1992

No. 336 1

__________________

Health Insurance (1992-1993 Pathology Services Table) Regulations

I, The Governor-General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following Regulations under the Health Insurance Act 1973.

 Dated 20 October 1992.

 BILL HAYDEN

 Governor-General

 By His Excellency’s Command,

B. HOWE

Minister of State for Health, Housing

and Community Services

____________

Citation

 1. These Regulations may be cited as the Health Insurance (1992-1993 Pathology Services Table) Regulations.

Commencement

 2.These Regulations commence on 1 November 1992.

Repeal

 3. Statutory Rules 1991 No. 442, and 1992 Nos. 23, 46 and 273 are repealed.

Pathology services table

 4.The table of pathology services in the Schedule is prescribed for the purposes of subsection 4a (2) of the Health Insurance Act 1973.

SCHEDULE

TABLE OF PATHOLOGY SERVICES

RULES OF INTERPRETATION

1.

(1)  In this table, unless the contrary intention appears:

“patient episode” means:

• (a)

  a pathology service to which rule 3a refers that is provided in the circumstances described in that rule that relate to the service; and

• (b)

  except in the case of a pathology service to which paragraph (a) refers—a pathology service or pathology services, whether specified in a single item or in more than 1 items, provided for a single patient whose need for the service or services was determined under subsection 16a (1) of the Act on the same day, whether rendered by an approved pathology practitioner or more than 1 approved pathology practitioner on the same day or on different days;

“recognised pathologist” means a medical practitioner recognised as a specialist in pathology under a determination under subsection 61 (3) of the Act;

“the Act” means the Health Insurance Act 1973.

(2)

In these Rules, a reference to a request to an approved pathology practitioner includes a reference to a request for a pathologist-determinable service to which subsection 16a (6) of the Act applies.

SCHEDULE—continued

(3)

Unless the contrary intention appears, a reference in this table by number to an item that is not included in this table is a reference to the correspondingly numbered item in the general medical services table or the diagnostic imaging services table, as each case requires.

 2.(1) If a service is described:

• (a)

  in an item in general terms; and

• (b)

  in another item in specific terms:

only the item that describes the service in specific terms applies to the service.

(2)

If:

• (a)

  a service is described in 2 or more items; and

• (b)

  subrule (1) does not apply;

only the item that provides the lower or lowest fee for the service applies to the service.

 3.(1)In subrule (2), “service” includes an assay, estimation and test. 

 (2) Subject to rule 3a, 2 or more pathology services rendered for a patient following 2 or more requests are taken to have been rendered following a single request if:

• (a)

  the services are listed in the same item; and

• (b)

  the patient’s need for the services was determined under subsection 16a (1) of the Act on the same day even if they are rendered by an approved pathology practitioner on more than one day.

 3a. (1) Rule 3 does not apply to:

• (a)

  a pathology service specified in item 66201, other than an estimation of cholesterol, fructosamine, lithium or triglycerides; or

• (b)

  the quantitative estimation of 1 or more fractions of neonatal bilirubin specified in item 66273;

if:

SCHEDULE—continued

• (c)

  the service is rendered in relation to a single specimen taken on each of not more than 4 occasions in a period of 24 hours; and

• (d)

  the service is rendered to a patient in a hospital unit where:

  • (i)

    the presence of 1 nurse is required for each group of not more than 4 patients; and

  • (ii)

    the condition of the patients is continuously observed in relevant respects; and

• (e)

  in order to render the service, an approved pathology practitioner who is a recognised pathologist has to arrange for a member of the laboratory staff of the approved pathology authority concerned to undertake duties in respect of the service that are in addition to the usual duties of the staff member.

(2)

Rule 3 does not apply to any of the following pathology services rendered in relation to a single specimen taken on each of not more than 6 occasions in a period of 6 months:

• (a)

  estimation of prothrombin time in respect of a patient undergoing anticoagulant therapy;

• (b)

  quantitative estimation of lithium in respect of a patient undergoing lithium therapy;

• (c)

  a service specified in item 65007 in relation to a patient undergoing chemotherapy for neoplastic disease or immunosuppressant therapy;

• (d)

  a service specified in item 65007 in relation to methotrexate, gold or penicillamine therapy of a patient;

• (e)

  a service specified in item 66201 in relation to methotrexate therapy of a patient;

• (f)

  quantitative estimation of urea, creatinine and electrolytes in relation to:

  • (i)

    cis-platinum therapy of a patient; or

  • (ii)

    chronic renal failure of a patient being treated in a dialysis program conducted by a recognised hospital.

(3)

This rule does not apply in relation to a pathology service unless the account for fees in respect of the service is endorsed with the words “Rule 3 Exemption”.

SCHEDULE—continued

 4. If:

• (a)

  a pathology service to which an item of the table applies is rendered for a patient in accordance with a request; and

• (b)

  another pathology service is rendered for the patient in accordance with the request; and

• (c)

  an item of the table:

  • (i)

    applies to the other service; and

  • (ii)

    is referred to in the item mentioned in paragraph (a);

the other service is treated as if it were part of the service referred to in paragraph (a).

 Example:

• Dr Proctor requests an extended blood grouping test (covered by item 65019) and the test includes a basic blood grouping test (covered by item 65017).

  Item 65017 is referred to in item 65019. Benefit is payable under item 65019 for the extended blood grouping test but benefit is not payable separately under item 65017 for the basic blood grouping test.

 5. For the purposes of items 65001 to 66200 (inclusive):

• (a)

  if pathology services of a kind referred to in item 65017 or 65019 are rendered for a patient during a period when the patient is in hospital, the item applies only to the first pathology service of that kind rendered for the patient during that period; and

• (b)

  tests (except the tests mentioned in item 65023) carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request is made within 14 days of that previous patient episode.

 5a. (1) In this rule:

“designated pathology service” means a pathology service specified in item 66241, 66313 or 69241.

SCHEDULE—continued

(2)

Subject to subrule (3), if an approved pathology practitioner in an approved pathology authority:

• (a)

  has been requested to render a pathology service that specified 2 or more estimations comprised in a designated pathology service; and

• (b)

  is unable to perform 1 or more, but not all, of the estimations because of the lack of facilities in, or expertise or experience of the staff of, the laboratory of the authority in relation to that estimation or those estimations; and

• (c)

  requests an approved pathology practitioner in another approved pathology authority to render 1 or more, but not all, of the estimations;

the service rendered by the second-mentioned practitioner is taken to be the designated pathology service.

(3)

Items 73901 to 73917 (inclusive) do not apply to the second-mentioned approved pathology practitioner in subrule (2).

 6. For the purposes of items 66201 to 69200 (inclusive):

• (a)

  if a pathology service involving the measurement of a substance in urine requires a 24 hour urine collection, or calculation of a substance/creatinine ratio, the service is treated as including any estimation of creatinine in other fluids necessary for the calculation; and

• (b)

  tests carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request is made within 14 days of that previous patient episode.

 7. For the purposes of items 69201 to 71000 (Inclusive):

• (a)

  “serial examinations or cultures” means examinations or cultures requested on 1 occasion whether or not;

  • (i)

    the materials are received on different days by the approved pathology practitioner; or

  • (ii)

    the examinations or cultures were requested on 1 or more request forms by the treating practitioner; and

SCHEDULE—continued

• (b)

  tests carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request occurs within 14 days of that previous patient episode.

 8. For the purposes of items 71001 to 72800 (inclusive):

• (a)

  in items 71025, 71027, 71029 and 71031, the estimation of a single antibody includes qualitative and quantitative assays for that antibody; and

• (b)

  tests carried out on material stored from a previous patient episode in response to a later request are treated as part of that previous patient episode if the second request occurs within 14 days of that previous patient episode.

 9. For the purposes of items 72801 to 73040 (inclusive):

• (a)

  “biopsy material” means all tissue received by the approved pathology practitioner from an operation, or a group of operations, performed on a patient at the same time, other than a bone marrow biopsy; and

• (b)

  if:

  • (i)

    a pathology service that is the examination of biopsy material is rendered under any of those items; and

  • (ii)

    a further pathology service mentioned in any of those items is also rendered using that biopsy material;

 those pathology services are treated as 1 pathology service.

 10. for the purposes of items 73041 to 73280 (inclusive), “serial examinations” means examinations requested on 1 occasion whether or not:

• (a)

  the materials are received on different days by the approved pathology practitioner; or

• (b)

  the examinations were requested on 1 or more request forms by the treating practitioner.

SCHEDULE—continued

 11.(1) For the purposes of this rule and items 73901 to 73921 (inclusive):

“approved pathology authority” has the same meaning as in Division 4a of Part IIa of the Act;

“institution” means a place (other than a hospital, a nursing home or accommodation for aged persons that is attached to a nursing home or situated within a nursing home complex) at which residential accommodation or day care is, or both residential accommodation and day care are, made available to:

• (a)

  disadvantaged children; or

• (b)

  juvenile offenders; or

• (c)

  aged persons; or

• (d)

  chronically ill psychiatric patients; or

• (e)

  homeless persons; or

• (f)

  unemployed persons; or

• (g)

  persons suffering from alcoholism; or

• (h)

  persons addicted to drugs; or

• (i)

  physically or mentally handicapped persons.

“licensed collection centre” has the same meaning as in Part IIa of the Act;

“prescribed laboratory” means a laboratory operated by:

• (a)

  the Commonwealth; or

• (b)

  a State; or

• (c)

  an authority of a State or Territory; or

• (d)

  the Northern Territory; or

• (e)

  the Australian Capital Territory; or

• (f)

  an Australian tertiary education institution.

“specimen collection centre” has the same meaning as in Part IIA of the Act;

“temporary collection centre” has the same meaning as in Part IIA of the Act;

“treating practitioner” has the same meaning as in paragraph 16A (1)(a) of the Act.

SCHEDULE—continued

(2)

A service mentioned in items 73901 to 73921 (inclusive) applies to a pathology service when rendered by, or on behalf of, an approved pathology practitioner who is a recognised pathologist unless:

• (a)

  the service is rendered upon a request made in the course of an out-patient service at a recognised hospital; or

• (b)

  the service is rendered upon a request made for a patient who is a private patient in a recognised hospital when the request was made; or

• (c)

  the pathology equipment of a recognised hospital, or prescribed laboratory, is used rendering the service; or

• (d)

  a member of the staff of a recognised hospital, or prescribed laboratory, participates in the service in the course of the member’s employment with the hospital or laboratory.

(3)

A service mentioned in items 73901 to 73921 (inclusive) does not apply to a pathology service:

• (a)

  to which subsection 16a (7) of the Act applies; or

• (b)

  unless at least one of items 65001 to 73529 (inclusive) also applies to that service.

(4)

If one item of items 73901 to 73917 (inclusive) applies to a patient episode, none of the remainder of those items applies to that patient episode.

(5)

Item 73921:

• (a)

  applies only to the approved pathology practitioner or approved pathology authority to whom the specimen mentioned in the item was referred; and

 11a. If item 73921 applies to a patient episode, none of items 73901 to 73917 (inclusive) applies to any pathology service rendered by the approved pathology authority or the approved pathology provider in respect of that patient episode.

 12. The abbreviations at the end of the table may be used to identify particular pathology services or groups of pathology services.

SCHEDULE—continued

SERVICES AND FEES

 

GROUP P1—HAEMATOLOGY

65001	Blood count consisting of erythrocyte count, C-reactive protein, erythrocyte sedimentation rate, blood viscosity, haematocrit, haemoglobin, platelet count, leucocyte count, reticulocyte count—1 or 2 procedures	$5.60
65003	3 or more procedures to which item 65001 applies, including any calculation or measurement of erythrocyte or other indices	$7.60
65005	Examination of blood film, with or without 5 part differential cell count, or 5 part differential cell count with or without examination of blood film, and if performed, any of these additional services—Direct Coombs test, tests for heterophile antibodies, cold agglutinins, examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron, or examination of a blood film with alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphatase, nitroblue tetrazolium, periodic acid Schiff, Sudan Black stains, or Kleihauer test for HbF on blood film, including any services specified in item 65027	$10.00
65007	Full blood examination consisting of items 65003 and 65005	$17.30
65009	Erythrocytes, qualitative or quantitative assessment of haemolysis or metabolic enzymes by—erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test, and quantitation of muramidase in serum or urine - 1 or more procedures	$23.00
65011	Tests for the diagnosis of haemoglobinopathy consisting of haemoglobin electrophoresis and 2 of the following—examination for HbH, quantitation of HbA2 or HbF, including any services specified in items 65001, 65003, 65005 and 65007	$36.00

SCHEDULE—continued

65013	Histopathological examination of sections of bone marrow trephine biopsy including where indicated, examination of marrow smears and any special stains and immunochemical techniques, including any services specified in items 65001, 65003, 65005, 65007 and 65015	$110.00
65015	Bone marrow examination of aspirated material including any special stains, immunochemical techniques and clot sections where necessary, including any services specified in items 65001, 65003, 65005 and 65007	$80.00
65017	Blood grouping, including back-grouping when performed—ABO and Rh (D antigen)	$9.70
65019	Blood grouping—Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system—1 or more systems, including any services specified in item 65017	$19.20
65021	Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 65001, 65003, 65005 and 65007	$36.00
65023	Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and, if necessary, quantitative estimation of any antibodies detected and any services specified in items 65001, 65003, 65005, 65007, 65017 and 65021 including all testing performed on any 1 day	$88.00
65025	Examination of serum for blood group antibodies including identification and, if necessary, quantitative estimation of any antibodies detected	$15.80
65027	Direct Coombs test, qualitative or quantitative test for cold agglutinins, or heterophile antibodies, qualitative spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins and detection of metalbumin (Schumm’s test) including those services specified in items 65005 and 65007 - 1 or more tests	$8.80

SCHEDULE—continued

65029	Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), test for factor XIII deficiency, fibrinogen, or 1 of—fibrinogen degradation products, fibrin monomer or D-dimer—1 estimation	$12.10
65031	2 estimations specified in item 65029	$16.00
65033	3 estimations specified in item 65029	$19.90
65035	4 or more estimations specified in item 65029	$23.80
65037	Quantitative assay, by 1 or more techniques, of plasminogen, antithrombin III, Protein C, Protein S, heparin cofactor II, euglobulin clot lysis time and test for lupus anticoagulant—1 estimation	$24.00
65039	4 or more estimations specified in item 65037	$76.00
65041	Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance—1 or more estimations	$47.50
65043	Heparin assay, only when monitoring a patient on subcutaneous heparin or low molecular weight heparin —1 or more estimations	$31.50
65045	Quantitative assay of Von Willebrand’s factor antigen (factor VIII related antigen), Von Willebrand’s factor (ristocetin cofactor), factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, Passovy factor —1 estimation	$31.70
65047	2 estimations as specified in item 65045	$45.70
65049	3 or more estimations as specified in item 65045	$59.70

SCHEDULE—continued

GROUP P2—CHEMICAL
66201	Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis of—alanine aminotransferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 66245), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, triglycerides, urate, urea - 1 estimation	$9.80
66203	2 estimations specified in item 66201	$11.85
66205	3 estimations specified in item 66201	$13.90
66207	4 estimations specified in item 66201	$15.95
66209	5 estimations specified in item 66201	$18.00
66211	6 or more estimations specified in item 66201	$20.10
66213	Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents—bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in plasma - 1 or more estimations	$9.50
66215	Quantitative estimation of cryoglobulins or cryofibrinogen after a positive result for cryoglobulin is obtained in any service specified in item 66213 (including provision of that service)—1 or more estimations	$14.40
66217	Qualitative estimation by any method except by reagent strip or dip-stick of the following faecal constituents—haemoglobin, porphyrins, reducing substances—each estimation, to a maximum of 3 estimations, taken on separate days

   

$6.30

SCHEDULE—continued

66219	Immunological detection of human haemoglobin in faeces, including any additional services specified in item 66217—1 estimation in any 28 day period	$12.00
66223	Osmolality, estimation by osmometer, in serum or in urine—1 or more estimations	$24.00
66225	Quantitative estimation of blood gases including tests performed from—pO2, oxygen saturation, pCO2, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen—1 or more estimations on 1 specimen	$32.50
66227	Estimation of blood gases as specified in item 66225 on each specimen in excess of 1 to a maximum of 6 specimens within any 1 day	$8.60
66229	Calculus, analysis of 1 or more	$29.50
66231	Drug or chemical assays—including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any services specified in items 66235, 66237 and 66239, but excluding the surveillance of sports people and athletes for performance improving substances—1 or more assays	$40.00
66233	Drug assays—including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programmes—each assay to a maximum of 4 assays within any 28 day period	$20.00
66235	Drug assay —quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken and not elsewhere specified in the Schedule—1 estimation	$20.00

SCHEDULE—continued

66237	2 estimations specified in item 66235	$28.00
66239	3 or more estimations specified in item 66235	$36.00
66241	Estimations specified in any of items 66235 to 66239 (inclusive), if the number of estimations relating to the same patient episode does not exceed 3—each estimation to a maximum of 2 estimations	$8.00
66243	Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio, palmitic acid, phosphatidylglycerol or lamellar body phospholipid—1 or more examinations or estimations	$31.50
66245	Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, or the isoenzymes of lactate dehydrogenase, alkaline phosphatase and creatine kinase or lipoprotein electrophoresis (only when the cholesterol is >6.5mmol/l and triglyceride >3.0 mmol/l or in the diagnosis of types III and IV hyperlipidaemia), including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activity—1 examination to a maximum of 2 examinations in any 12 month period	$29.50
66247	Electrophoresis, quantitative or qualitative of concurrently collected, or collected within a 28 day period, serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, including the preliminary quantitation of total protein, albumin and globulin, or of total relevant enzyme activity—2 or more examinations	$44.00
66255	Alpha-1-acid glycoprotein, alpha-1-antitrypsin, alpha-2-macroglobulin, quantitative estimation in serum, urine or other body fluid—1 or more estimations	$19.40
66257	C-1 esterase inhibitor, quantitative estimation	$19.40
66258	C-1 esterase inhibitor, functional assay	$43.50

SCHEDULE—continued

66259	Alpha-fetoprotein, beta-2-microglobulin, caeruloplasmin, ferritin (except when part of item 66263), haptoglobulins, microalbumin in proven diabetes mellitus, prealbumin, prostate specific antigen, prostatic acid phosphatase, transferrin (except when part of item 66263) - quantitative estimation in serum, urine or other body fluid—1 estimation	$19.40
66260	2 or more estimations as specified in item 66259	$36.00
66261	CA-125 antigen, CA-15.3 antigen, CA-19.9 antigen, carcinoembryonic antigen (CEA), mammary serum antigen, mucin-like carcinoma associated antigen (1 or more fractions), neuron-specific enolase, thyroglobulin in serum or other body fluid, in the monitoring or confirmation of malignancy, quantitative estimation—1 estimation	$19.40
66262	2 or more estimations specified in item 66261	$36.00
66263	Iron studies consisting of quantitative analysis of iron, transferrin or iron binding capacity and ferritin	$38.00
66265	Serum B12, serum folate—1 or more estimations within any 28 day period	$24.00
66267	Red cell folate and serum B12 and, if required, serum folate, to a maximum of 3 estimations in any 12 month period	$43.50
66269	Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of vitamins A, B1, B2, B3, B6, C, and E —1 or more estimations within any 6 month period	$29.50
66271	Vitamin D or D fractions - 1 or more estimations	$29.50
66273	Acetoacetate, alcohol, amino acids, ammonia, angiotensin converting enzyme, betahydroxybutyrate, cholinesterase, cystine (cysteine), total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, neonatal bilirubin (1 or more fractions), oxalate, pyruvate, serotonin, xylose, zinc—1 quantitative estimation	$24.00
66275	2 or more estimations specified in item 66273	$37.50

SCHEDULE—continued

66277	Aluminium (except if item 66325 applies), arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium, in blood, urine or other body fluid or tissue—1 or more estimations in any 6 month period	$34.50
66279	Blood lead estimation, other than for occupational health screening purposes, to a maximum of 3 estimations in any 6 month period—each estimation	$29.50
66281	Porphyrins (1 or more fractions), catecholamines (1 or more fractions), hydroxymethoxymandelic acid (HMMA), homovanillic acid (HVA), metanephrines, methoxyhydroxyphenylethylene glycol (MHPG), phenylacetic acid (PAA)—quantitative including any qualitative estimations—1 or more estimations	$38.50
66283	Faecal fat, breath hydrogen measurements in response to loading with disaccharides—1 or more quantitative estimations within any 28 day period	$38.50
66285	Solid tissue or tissues excluding blood elements—assay of 1 or 2 enzymes	$38.50
66287	Assay of 3 to 5 enzymes as specified in item 66285	$72.00
66289	Assay of 6 or more enzymes as specified in item 66285	$95.00
66291	Thyroid function tests, including thyrotrophin (TSH) and at least 1 or more of the following tests—free thyroxine index, free thyroxine, free T3, total T3, thyroxine binding globulin	$40.00
66293	Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones	$47.50
66295	Growth hormone suppression by glucose loading, growth hormone stimulation by exercise, dexamethasone suppression test, L-dopa stimulation of growth hormone, where physically performed by a recognised pathologist—1 or more procedures	$11.40

SCHEDULE—continued

66297	Gonadotrophin releasing hormone stimulation test, synacthen stimulation test, glucagon stimulation test with C-peptide measurement, pentagastrin stimulation of thyrocalcitonin release, secretin stimulation of gastrin release, insulin hypoglycaemia, arginine infusion, where physically performed by a recognised pathologist—1 procedure	$38.00
66299	2 or more tests specified in item 66297	$60.00
66301	Hormones and hormone binding proteins, quantitative estimation by any method of—ACTH, aldosterone, androstenedione, C-peptide, calcitonin, cortisol, cyclic AMP, DHEAS, 11-deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, human placental lactogen, hydroxyprogesterone, insulin, LH, oestradiol, oestriol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(IgF1), free or total testosterone, TSH (where not requested as part of a thyroid function test), urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (antidiuretic hormone)—1 estimation	$30.80
66303	2 estimations specified in item 66301	$41.60
66305	3 estimations specified in item 66301	$52.40
66307	4 estimations specified in item 66301	$63.20
66309	5 estimations specified in item 66301	$74.00
66311	6 or more estimations specified in item 66301	$84.80
66313	Estimations specified in any of items 66301 to 66311 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6—each estimation to a maximum of 5 estimations	$10.80
66315	Hormone receptor assay on proven primary breast or ovarian carcinoma or a metastasis from a breast or ovarian carcinoma or a subsequent lesion in the breast—1 or more assays	$77.00

SCHEDULE—continued

66317	HDL cholesterol, or apolipoprotein B/A1 ratio, estimation of, in patients with serum cholesterol >5.5mmol/l or those on prescribed lipid lowering drugs or with a fasting serum triglyceride level > 2.0 mmol/1—each estimation to a maximum of 4 estimations in any 12 month period	$12.00
66319	Glycosylated haemoglobin only when performed in the management of established diabetes—each estimation to a maximum of 4 estimations in any 12 month period	$16.20
66321	Quantitative estimation in the 2nd trimester of pregnancy of alpha-fetoprotein, human chorionic gonadotrophin and oestriol and any other substance to detect foetal abnormality, including any service specified in 1 or more of items 66259, 66301, 73527 or 73529—1 patient episode in that pregnancy	$53.00
66323	Estimation of tryptic activity in faeces for the investigation of diarrhoea of greater than 4 weeks duration in children less than 6 years of age	$10.80
66325	Estimation of serum aluminium in a patient in a renal dialysis program—each estimation	$34.50
GROUP P3 - MICROBIOLOGY
69201	Microscopic examination of material other than blood, from 1 or more sites, obtained directly from a patient and excluding material from cultures—wet film, including differential cell count if performed, examination for dermatophytes or dark ground illumination, or stained preparation or preparations using any relevant stain or stains—1 or more examinations	$7.20
69203	Microscopic examination of faeces for parasites using concentration techniques including the use of appropriate stains, to a maximum of 3 estimations taken on separate days including any services specified in item 69201—each estimation	$12.00

SCHEDULE—continued

69205	The cultural examination and microscopical examination when indicated (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from nasal swabs, throat swabs, eye swabs and ear swabs, including pathogen identification and antibiotic sensitivity testing, including any services specified in item 69201—1 or more sites	$18.80
69207	Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from the following sites - skin or other superficial sites, urethra, vagina, cervix or rectum (except for faecal pathogens), or specimens of sputum (except when part of item 69213), including pathogenic identification and antibiotic sensitivity testing, including any services specified in items 69201 and 69205—1 or more examinations on 1 or more specimens	$27.50
69209	Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of postoperative wounds, aspirations of body cavities, synovial fluid, CSF and operative or biopsy specimens for the presence of pathogenic micro-organisms, including fungi but excluding viruses, involving aerobic and anaerobic culture and the use of different culture media and including pathogen identification and antibiotic sensitivity testing, including any services specified in items 69201, 69205 and 69207—1 or more sites	$37.50
69211	Cultural examination (including the detection of clostridial toxins or antigens not elsewhere specified in the Schedule) of faeces to determine the presence or absence of faecal pathogens, involving the use of at least 2 selective or enrichment media as well as culture in at least 2 different atmospheres and includes pathogen identification and antibiotic sensitivity testing, including any services specified in item 69201, to a maximum of 3 specimens in any 7 day period—each examination	$45.50

SCHEDULE—continued

69213	Microscopy with appropriate stains and cultural examinations of 3 specimens of sputum, urine or other bodily fluids for mycobacteria and any other bacterial pathogens, including pathogen identification and antibiotic sensitivity testing and including any services specified in item 69201	$63.00
69215	Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing —each set of cultures to a maximum of 3 sets	$16.60
69217	Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts (simple culture by dip slide is excluded from this item)	$20.10
69219	Direct detection of the antigens of Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus (in CSF and urine specimens only), RSV, cryptococcal antigens and Varicella zoster or detection of Clostridium difficile toxin except where item 69211 has been performed—1 or more estimations	$15.80
69221	Direct detection of Chlamydia from clinical material, not cultures—1 or more estimations	$9.50
69223	Direct detection of herpes simplex virus from clinical material, not cultures—1 or more estimations	$9.50
69225	Investigation for herpes simplex virus (1 or more types) or Chlamydia trachomatis, in material obtained directly from a patient, by 1 or more cultural methods, including any services specified in items 69221 and 69223	$27.50
69229	Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule—estimation of 1 antibody	$13.60
69231	2 estimations specified in item 69229	$20.80

SCHEDULE—continued

69233	3 estimations specified in item 69229	$28.00
69235	4 estimations specified in item 69229	$35.20
69237	5 estimations specified in item 69229	$42.40
69239	6 or more estimations specified in item 69229	$49.60
69241	Estimations specified in any of items 69229 to 69239 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6—each estimation to a maximum of 5 estimations	$7.20
69243	Hepatitis B surface antigen test	$13.40
69245	Hepatitis B serology to define the immune status of an individual, including at least hepatitis B surface antibody or hepatitis B core antibody tests, including services specified in items 69243, 69247 and 69249	$18.20
69247	All serological tests performed for the identification of the agent causing acute hepatitis, which must include hepatitis B surface antigen, hepatitis B core antibody and hepatitis A IgM antibody tests and those services specified in items 69243, 69245 and 69249	$36.00
69249	All tests performed in the follow up of a patient with proven hepatitis B, including hepatitis B surface antigen and either hepatitis B antigen or hepatitis B surface antibody tests, including services specified in items 69243 and 69245	$26.00
69251	Antibiotics or antimicrobial chemotherapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent—1 or more estimations	$24.00
69253	All microbiological serology during a pregnancy, which must include the determination of 1 of the following—rubella immune status, specific syphilis serology or hepatitis B surface antigen—including any service specified in 1 or more of items 69229, 69243 or 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy	$13.60

SCHEDULE—continued

69255	All microbiological serology during a pregnancy, which must include the determination of 2 of the following—rubella immune status, specific syphilis serology or hepatitis B surface antigen and including any service specified in 1 or more of items 69229, 69243 or 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy	$21.00
69257	All microbiological serology during a pregnancy, which must include the determination of all 3 of the following - rubella immune status, specific syphilis serology and hepatitis B surface antigen—including any service specified in 1 or more of items 69229, 69243 or 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy	$27.50
GROUP P4 - IMMUNOLOGY
71061	Examination for, and characterisation of, a paraprotein or cryoglobulin not previously characterised on serum, urine or other body fluid by immunoelectrophoresis or immunofixation - 1 or more procedures	$28.00
71063	Examination for, and characterisation of, a paraprotein not previously characterised, by immunoelectrophoresis or immunofixation on serum and urine collected concurrently—2 or more procedures	$42.50
71065	Examination of CSF and serum concurrently for the presence of oligoclonal proteins—2 or more procedures	$42.50
71067	Immunoglobulins A, G, M or D, quantitative estimation by any method in serum, urine or other body fluid—1 estimation	$14.50
71069	2 estimations as specified in item 71067	$22.90
71071	3 or more estimations as specified in item 71067	$31.30
71073	Immunoglobulin G subclasses, quantitative estimation of all 4 subclasses with a maximum of 2 patient episodes in any 12 month period - each patient episode	$102.00

SCHEDULE—continued

71075	Immunoglobulin E (total), quantitative estimation with a maximum of 2 patient episodes in any 12 month period—each patient episode	$26.00
71077	Immunoglobulin E (total), quantitative estimation in the follow up of a patient with proven immunoglobulin E secreting myeloma, proven congenital immunodeficiency or proven allergic bronchopulmonary aspergillosis, with a maximum of 6 patient episodes in any 12 month period—each patient episode	$26.00
71079	Estimation of specific immunoglobulin G or E antibodies to single or multiple potential allergens, with a maximum of 4 patient episodes in any 12 month period—each patient episode	$23.50
71081	Total haemolytic complement, quantitative estimation	$19.40
71083	Complement components C3, C4 or properdin factor B, quantitative estimation —1 estimation	$19.40
71085	2 estimations as specified in item 71083	$27.90
71087	3 or more estimations as specified in item 71083	$36.40
71089	Complement components or breakdown products of complement proteins not elsewhere specified in an item in this Schedule, quantitative estimation—1 estimation	$28.10
71091	2 estimations as specified in item 71089	$50.90
71093	3 or more estimations as specified in item 71089	$73.70
71097	Antinuclear antibodies, detection in serum or other body fluids, including quantitation if required	$24.50
71099	Double-stranded DNA antibodies, quantitative estimation by 1 or more methods other than the Crithidia method	$25.50
71101	Antibodies to 1 or more extractable nuclear antigens, detection in serum or other body fluids

 

$16.80

SCHEDULE—continued

71103	Antibodies to 1 or more extractable nuclear antigens, characterisation after a positive result is obtained by a service specified in item 71101, including that service	$50.00
71105	Rheumatoid factor, detection by any technique	$8.40
71107	Quantitation of rheumatoid factor if detected, during a service specified in item 71105, including that service	$19.40
71109	Antibodies to tissue antigens (acetylcholine receptor, adrenal cortex, cardiolipin, glomerular basement membrane, heart, histone, insulin, insulin receptor, intrinsic factor, islet cell, lymphocyte, neuron, neutrophil cytoplasm, ovary, parathyroid, platelet, salivary gland, skeletal muscle, skin basement membrane and intercellular substance, thyroglobulin, thyroid microsome, thyroid stimulating hormone receptor), qualitative or quantitative—estimation of 1 antibody	$33.30
71113	Estimation of 2 antibodies specified in item 71109	$50.00
71115	Estimation of 3 antibodies specified in item 71109	$62.30
71117	Estimation of 4 antibodies specified in item 71109	$70.60
71119	Antibodies to tissue antigens not elsewhere specified in an item in this Schedule, qualitative or quantitative—estimation of 1 antibody	$16.70
71121	Estimation of 2 antibodies specified in item 71119	$20.00
71123	Estimation of 3 antibodies specified in item 71119	$23.30
71125	Estimation of 4 or more antibodies specified in item 71119	$26.60
71127	Functional tests for lymphocytes—estimation of proliferation induced by 1 or more mitogens, estimation of proliferation induced by 1 or more antigens or estimation of 1 or more mixed lymphocyte reactions, other than quantitation by microscopy—including a test specified in item 65005, with a maximum of 2 patient episodes in any 12 month period—each patient episode	$170.00
71129	2 estimations specified in item 71127	$210.00

SCHEDULE—continued

71131	3 or more estimations specified in item 71127	$250.00
71135	Determination of neutrophil function - comprising at least 2 of neutrophil chemotaxis, neutrophil phagocytosis, neutrophil oxidative metabolism, neutrophil bactericidal activity—including any test specified in item 65005 (other than nitroblue tetrazolium reduction slide test), with a maximum of 2 patient episodes in any 12 month period—each patient episode	$200.00
71137	Determination of cell mediated immunity by multiple antigen delayed type hypersensitivity intradermal skin testing using a minimum of 7 antigens, with a maximum of 2 patient episodes in any 12 month period—each patient episode	$29.00
71139	Characterisation of 3 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations on 1 or more specimens of blood, CSF or serous fluid	$100.00
71141	Characterisation of 3 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations on 1 or more disaggregated tissue specimens	$220.00
71143	Characterisation (not monitoring) of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations in an immunological or haematological malignancy, including any service specified in 1 or more of items 71139 or 71141, on a specimen of blood, CSF, serous fluid or disaggregated tissue	$250.00
71145	Characterisation (not monitoring) of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations in an immunological or haematological malignancy, including any service specified in 1 or more of items 71139, 71141 or 71143, on 2 or more specimens of disaggregated tissues or 1 specimen of disaggregated tissue and 1 or more specimens of blood, CSF or serous fluid	$410.00
71147	HLA-B27 typing	$33.50

SCHEDULE—continued

71149	Complete tissue typing for 4 HLA-A and HLA-B Class I antigens (including any separation of leucocytes), including any service specified in item 71147	$104.00
71151	Tissue typing for HLA-DR, HLA-DP and HLA-DQ Class II antigens (including any separation of leucocytes)—phenotyping or genotyping of 2 or more antigens	$114.00
GROUP P5 - HISTOPATHOLOGY
72801	Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions	$77.00
72803	Immediate frozen section diagnosis of biopsy material, including any other histopathology examination	$126.00
72805	Immunohistochemical investigation of biopsy material by 1 or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination	$95.00
72807	Electron microscopy of biopsy material including any other histopathology examination	$102.00
GROUP P6 - CYTOPATHOLOGY
73043	Cytological examination including serial examinations of smears from skin, nipple discharge, lip, mouth, nose or anus for detection of precancerous or cancerous changes—1 or more examinations	$14.60
73045	Cytological examination, other than an examination mentioned in item 73053, for malignancy, including serial examinations and histological services performed on the resulting specimens from washings or brushings from sites not specified in item 73043, or performed on a single specimen of sputum or urine or on 1 or more specimens of other body fluids—1 or more examinations	$28.50
73047	Cytological examination including examination of a series of 3 sputum or urine specimens for malignant cells	$60.00

SCHEDULE—continued

73049	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues	$36.00
73051	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist; or where  a recognised pathologist attends the aspiration and performs cytological examination during the attendance	$67.00
73053	Routine cytological examination of smears from cervix for detection of precancerous or cancerous changes in women with no symptoms, signs or recent history suggestive of cervical neoplasia and smears repeated due to an unsatisfactory routine smear—each examination	$12.20
73055	Cytological examination of smears from cervix in association with the management of previously detected abnormalities including precancerous or cancerous conditions, or the investigation of women with symptoms, signs or recent history suggestive of cervical neoplasia, not associated with item 73053—each examination	$12.20
73057	Cytological examination of smears from vagina, not associated with items 73053 or 73055—each examination	$12.20

GROUP P7 - CYTOGENETICS
73281	Chromosome studies, including preparation, count and karyotyping of 1 or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood—1 or more estimations	$130.00
73283	Chromosome studies, including preparation, count and karyotyping of blood	$118.00
73285	Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis); or by fragile X-site determination—1 or more identifications	$102.00

SCHEDULE—continued

GROUP P8 - INFERTILITY AND PREGNANCY TESTS
73521	Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test)	$6.60
73523	Semen examination (excluding post vasectomy semen examination), involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and 1 or more chemical tests, with a maximum of 4 examinations in any 12 month period	$27.50
73525	Sperm antibodies, sperm penetrating ability—1 or more tests	$17.80
73527	Chorionic gonadotrophin (beta-HCG), qualitative estimation in serum or urine by 1 or more methods, including serial dilution if performed, for diagnosis of pregnancy —1 or more estimations	$9.70
73529	Chorionic gonadotrophin (beta-HCG), qualitative (if performed) and quantitative estimation in serum by 1 or more methods for diagnosis of hydatidiform mole, HCG—secreting neoplasm, threatened abortion or follow up of abortion	$27.50
GROUP P9 - SIMPLE BASIC PATHOLOGY TESTS
73801	Seminal examination for presence of spermatozoa	$6.30
73802	Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count—1 procedure	$4.20
73803	2 procedures specified in item 73802	$6.30
73804	3 or more procedures specified in item 73802	$8.40
73805	Microscopical examination of urine	$4.20
73806	Pregnancy test by 1 or more immunochemical methods	$10.40
73807	Microscopical examination of wet film other than urine	$6.30

SCHEDULE—continued

73808	Microscopical examination of gram stained film	$8.00
73809	Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method	$2.10
73810	Microscopical examination screening for fungi in skin, hair or nails —1 or more sites	$6.30
73811	Mantoux test	$10.40
GROUP P10 - PATIENT EPISODE INITIATION
73901	Initiation of a patient episode which consists only of a service specified in item 73053, 73055 or 73057  from a person who is not in a recognised hospital or a prescribed laboratory	$7.70
73903	Initiation of a patient episode which consists only of a service specified in item 72801 from a person who is an in-patient of a hospital other than a recognised hospital	$13.80
73905	Initiation of a patient episode which consists only of a service specified in item 72801 from a person who is not an in-patient of a private hospital and not a patient of a recognised hospital	$7.70
73907	Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected in a licensed collection centre other than a temporary licensed collection centre	$15.80
73909	Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person who is an in-patient of a hospital other than a recognised hospital	$15.80

SCHEDULE—continued

73911	Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority, from a person in the place where the person was residing or in a nursing home or institution	$15.80
73913	Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905, 73907, 73917 and 73801 to 73811 (inclusive) where the specimen is collected from the person by the person	$9.70
73915	Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by or on behalf of the treating practitioner	$9.70
73917	Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected in a temporary licensed collection centre	$9.70
GROUP P11 - SPECIMEN REFERRED
73921	Referral of specimen by an approved pathology practitioner of an approved pathology authority to another approved pathology practitioner of another approved pathology authority or to another approved pathology authority	$9.70

 

SCHEDULE—continued

ABBREVIATIONS

A.

ABBREVIATIONS FOR GROUPS OF TESTS

  

 Estimations

GroupIncluded in GroupAbbreviationItem Numbers

  

Cardiac  Lactate dehydrogenase (LDH) CE 66205

Enzymes aspartate aminotransferase

 (AST) and

 creatine kinase (CK)

 

Coagulation Prothrombin time, COAG 65035

Studies activated partial thrombo-

 plastin time and two or

 more of the following tests-

 bleeding time, thrombin

 clotting time, fibrinogen

 degradation products,

 fibrin monomer, D-dimer,

 factor XIII screening tests

 

Electrolytes Sodium (NA) E 66207

 potassium (K)

 chloride (CL) and

 bicarbonate (HCO3)

 

Lipid Studies Cholesterol (CHOL) and FATS 66203

 triglycerides (TRIG)

 

Liver Function  Alkaline phosphatase (ALP), LFT 66211

Tests alanine aminotransferase

 (ALT),

 aspartate aminotransferase

 (AST),

 albumin (ALB),

 bilirubin (BIL),

 gamma glutamyl

 transpeptidase (GGT),

 lactate dehydrogenase (LDH),

 and protein (PROT)

 

SCHEDULE—continued

 

Syphilis Rapid plasma reagin test STS 69231

Serology (RPR) or venereal disease

 research laboratory

 test (VDRL) and

 treponema pallidum

 haemagglutination test (TPHA)

 or fluorescent treponemal

 antibody-absorption test

 (FTA)

 

Urea,  Urea,  U&E 66211

Electrolytes, electrolytes, 

Creatine creatinine

 

B. ABBREVIATIONS FOR INDIVIDUAL TESTS

 

Abnormal haemoglobins AH 65027

Acetoacetate ACAT 66273

Adrenocorticotrophic hormone (ACTH) ACTH 66301

AFB microscopy & culture of sputum AFB 69213

Alanine aminotransferase ALT 66201

Albumin ALB 66201

Alcohol (ethanol) ETOH 66273

Aldosterone ALDS 66301

Alkaline phosphatase ALP 66201

- isoenzymes

ALPI 66245

Alpha fetoprotein AFP 66259

- for Down syndrome testing

NTDD 66321

Alpha-1-antitrypsin AAT 66255

Alpha-1-acid glycoprotein AAG 66255

Alpha-2-macroglobulin AMG 66255

Aluminium AL 66277

- renal dialysis

ALR 66325

Amino acids AA 66273

Amiodarone AMIO 66235

Amitriptyline AMIT 66235

Ammonia NH3 66273

Amniotic fluid examination AFE 66243

Amylase AMS 66201

Amylobarb AMYL 66235

Androstenedione ANDR 66301

Angiotensin converting enzyme ACE 66273

Antibiotic & antimicrobial chemotherapeutic agents,

quantitative assay QAA 69251

SCHEDULE—continued

 

Antibodies to

 - extractable nuclear antigens

 - detection ENA 71101

 - characterisation of antibodies if positive ENA ENAP 71103

 - nuclear antigens

 - detection ANA 71097

 - quantitation & measurement of DNA

  binding if positive ANA  ANAP 71099

 - tissue antigens

 - acetylcholine receptor ARA 71109

 - adrenal cortex ADR 71109

 - cardiolipin ACL 71109

 - centromere ACA 71119

 - gastric parietal cell PCA 71119

 - gliadin IgA GLIA 71119

 - glomerular basement membrane GBA 71109

 - heart AHE 71109

 - histone AHI 71109

 - insulin AINS 71109

 - insulin receptor antibodies  INSA 71109

 - intercellular cement substance of skin ICCS 71109

 - intrinsic factor AIF 71109

 - islet cell AIC 71109

 - Jo-1 JO1 71119

 - keratin KERA 71119

 - liver/kidney microsomes LKA 71119

 - lymphocyte ALY 71109

 - mitochondria MA 71119

 - neuron ANE 71109

 - neutrophil cytoplasm ANCA 71109

 - ovary AOV 71109

 - parathyroid PTHA 71109

 - platelet APA 71109

 - PM-Sc1 PM1 71119

 - reticulin RCA 71119

 - salivary gland ASG 71109

 - Scl-70  SCL 71119

 - skeletal muscle SLA 71109

 - skin basement membrane SKA 71109

 - smooth muscle SMA 71119

 - thyroglobulin ATG 71109

 - thyroid microsome  TMA 71109

 - TSH receptor antibody test TSHA  71109

Antibody testing, microbial (see Microbial)

SCHEDULE—continued

 

Antigen testing, microbial

 (see Microbial)

Antithrombin III ATH 65037

Apolipoprotein B/A1 ratio APO 66317

Arginine infusion ARIN 66297

Arsenic AS 66277

Aspartate aminotransferase AST 66201

Barbiturate BARB 66235

Beryllium BE 66277

Beta-hydroxybutyrate BHYB 66273

Beta-2-microglobulin BMIC 66259

Bicarbonate HCO3 66201

Bilirubin (all fractions) BILI 66201

- neonatal

BILN 66273

Bleeding time BT 65029

Blood

- compatability testing

XMAT 65023

- culture

BC 69215

- film

BF 65005

- full examination

FBE 65001

- gases

GAS 66225

- group & blood group antibodies

BGAB 65021

- group antibodies

BGA 65025

- group systems

BGS 65019

- grouping-ABO & RH (D antigen)

BG 65017

- viscosity

VISC 65001

Bone marrow examination 

- aspirate

BMEA 65015

- trephine

BMET 65013

Breath hydrogen test BHT 66283

Bromide BRMD 66235

C-l esterase inhibitor

- quantitative

CEIQ 66257

- functional

CEIF 66258

C-Peptide CPEP 66301

C-reactive protein CRP 65001

CA-15.3 antigen CA15 66261

CA-l9.9 antigen CA19 66261

CA-125 antigen C125 66261

Cadmium CD 66277

Caeruloplasmin CPLS 66259

Calcitonin CALT 66301

Calcium (total, dialysed or ionized) CA 66201

Calculus analysis CALC 66229

Carbamazepine (Tegretol) CARB 66235

SCHEDULE—continued

 

Carboxyhaemaglobin COHB 65027

Carcinoembryonic antigen CEA 66261

Catecholamines CAT 66281

Chlamydia

- direct detection from clinical material

CHLY 69221

- investigation by cultural methods

CHLC 69225

Chloral hydrate CHHY 66235

Chlorazepate CHZP 66235

Chloride CL 66201

Chloroquine CLOQ 66235

Chlorpromazine CHLO 66235

Cholesterol CHOL 66201

- HDL

HDLC 66317

Cholinesterase CHSE 66273

Chorionic gonadotrophin

- for pregnancy diagnosis

HCG 73527

- for diagnosis of specified conditions

HCGD 73529

- for Down syndrome testing

NTDD 66321

Chromium CR 66277

Chromosome identification

- by banding technique

CSI 73285

- studies

CS 73281

- studies of blood

CSB 73283

Cimetidine CMTD 66235

Clobazam CLOB 66235

Clomipramine CLOM 66235

Clonazepam (Rivotril) CLON 66235

Clostridium difficile CLDT 69219

Coagulation

 - factors (see individual factors)

- time

CT 65029

Cold agglutinins CAG 65005, 65027

Compatability testing XMAT 65023

Complement, total haemolytic COM 71081

- components C3

C3 71083

- components C4

C4 71083

- properdin factor B

PFB 71083

- other components

COMP 71089

Copper CU 66277

Cortisol CORT 66301

Creatine kinase CK 66201

- isoenzymes

CKI 66201

- isoenzymes (electrophoresis)

CKIE 66245

Creatinine C 66201

SCHEDULE—continued

 

Cryofibrinogen 

- qualitative

CFID 66213

- quantitative

CFIE 66215

Cryoglobulins

- qualitative

CGLD 66213

- quantitative

CGLE 66215

- investigation by immunoelectrophoresis

   or immunofixation CRYO 71061

Cryptococcal antigen CRYN 69219

CSF antigens

- Haemophilus influenzae

HI 69219

- Streptoccus pneumoniae

SPN 69219

- Neisseria meningitidis

NMG 69219

- group B streptococcus

STB 69219

Cultural examination of faeces FCS 69211

Cylic AMP CAMP 66301

Cyclosporin A CLSA 66235

Cystine (cysteine)

- qualitative

UCYS 66213

- quantitative

CYST 66273

Cytology

 - from body fluids, sputum (1 specimen),

    urine, washings or brushings BFCY 73045

 - from cervix

 - routine CCR 73053

 - abnormalities CCRA 73055

- from fine needle aspiration of solid tissues

FNCY 73049

 - aspiration or attendance by a pathologist FNCP 73051

- from skin, nipple discharge, lip, mouth, nose or anus

SMCY 73043

- from vagina

CVO 73057

- from 3 sputum or urine specimens

SPCY 73047

D-dimer test DD 65029

Dehydroepiandrosterone sulphate  DHEA 66301

Deoxycortisol DCOR 66301

Desipramine DESI 66235

Dexamethasone DXST 66295

- suppression test

DEXA 66301

Diazepam DIAZ 66235

Differential cell count DIFF 65005

Digoxin DIG 66235

Dihydrotesterone DHTS 66301

Diphenylhydantoin (Dilantin) DIL 66235

Direct Coombs test CMBS 65005, 65027

Disopyramide (Rythmodan) DISO 66235

SCHEDULE—continued

 

DNA, double-stranded antibodies DNAD 71099

Down syndrome/neural tube defects NTDD 66321

Doxepin hydrochloride DOXE 66235

Drugs

- inappropriate dosage - assay

DRGO 66231

Electron microscopy of biopsy material EM 72087

Electrophoresis, to demonstrate

- creatine kinase isoenzymes

CKIE 66245

- lactate dehydrogenase isoenzymes

LDI 66245

- protein classes, or paraprotein

EPP1 66245

- protein classes or presence & amount of

   paraprotein classes, concurrent collection EPP2 66247

Elements (see individual elements)

Enzyme assays of solid tissue or tissues ENZS 66285

Erythrocyte

- assessment of haemolysis

ERYH 65009

- assessment of metabolic enzymes

ERYM 65009

- count

RCC 65001

- sedimentation rate

ESR 65001

Ethosuximide (Zarontin) ETHO 66235

Euglobulin clot lysis time ECLT 65037

Factor

- II

FII 65045

- V

FV 65045

- VII

FVII 65045

- VIII

VIII 65045

- IX

FIX 65045

- X

FX 65045

- XI

FXI 65045

- XII

FXII 65045

- XIII

XIII 65045

- XIII deficiency test

F13D 65029

Faecal fat FFAT 66283

- haemoglobin (chemical test)

FHC 66217

- haemoglobin (immunological test)

FHI 66219

- porphyrins (qualitative test)

FPR 66217

- reducing substances

FRS 66217

Faeces

- cultural examination

FCS 69211

- microscopic examination for parasites

OCP 69203

Ferritin (see also Iron studies) FERR 66259

Fibrin monomer FM 65029

Fibrinogen FIB 65029

- degradation products

FDP 65029

SCHEDULE—continued

 

Fitzgerald factor FGF 65045

Flecainide FLEC 66235

Fletcher factor FF 65045

Fluoxetine FLUX 66235

Follicle stimulating hormone  FSH 66301

Frozen section diagnosis of biopsy material FS 72803

Fructosamine FRUC 66201

Full blood examination FBE 65007

Gamma glutamyl transpeptidase GGT 66201

Gastrin GAST 66301

Globulin GLOB 66201

Glucagon GLGO 66301

Glucagon stimulation test GSTC 66297

Glucose GLUC 66201

- tolerance test

GTT 66201

Glycated haemoglobin (Hb Alc) GHB 66319

Gold AU 66277

Gonadotrophin  GRHS 66297

Group B streptococcus antigens STB 69219

Growth hormone GH 66301

- stimulation by exercise or L-dopa

GHSE 66295

- suppression by dexamethasone or glucose

GHSG 66295

Haematocrit HCT 65001

Haemoglobin estimation HB 65001

Haemoglobinopathy tests HMGP 65011

Haemophilus influenzae antigens HI 69219

Haloperidol HALO 66235

Haptoglobins HGLB 66259

HDL cholesterol HDLC 66317

Heparin

- cofactor II

HRNC 65037

- estimation

HEPR 65043

Hepatitis serology

- acute hepatitis

HEP 69247

- follow-up of proven hepatitis B

HEPB 69249

- hepatitis B serology to define immune status

HEP1 69245

- hepatitis B surface antigen HBsAg

HBSA 69243

- in pregnancy

HEPP 69253-57

- hepatitis C

HEPC 69229

- hepatitis delta antibody

HDA 69229

Herpes simplex virus

- direct detection from clinical material

HSV 69223

- investigation by cultural methods

HSVC 69225

Heterophile antibodies IM 65005, 65027

SCHEDULE—continued

 

HIAA (hydroxyindoleacetic acid) HIAA 66273

Histamine HIAM 66273

Histopathology of biopsy material HIST 72801

HLA typing

- HLA-B27

HLAB 71147

- HLA class 1

HLA1 71149

- HLA class 2

HLA2 71151

HMMA (hydroxy-3-methoxymandelic acid HMMA 66281

   previously known as VMA)

HMPG (hydroxy methoxy phenylethylene glycol) HMPG 66281

Homovanillic acid HVA 66281

Hormone receptor assay

- breast

HRA 66315

- ovary

HRO 66315

Hormones:

- adrenocorticotrophic hormone

ACTH 66301

- aldosterone

ALDS 66301

- androstanedione

ANDR 66301

- C-Peptide

CPEP 66301

- calcitonin

CALT 66301

- cortisol

CORT 66301

- cyclic AMP

CAMP 66301

- dehydroepiandrosterone sulphate

DHEA 66301

- dihydrotestosterone

DHTS 66301

- follicle stimulating hormone

FSH 66301

- gastrin

GAST 66301

- glucagon

GLGO 66301

- gonadotrophin

GRHS 66297

- growth hormone

GH 66301

 - stimulation by exercise or L-dopa GHSE 66295

 - suppression by dexamethasone or glucose GHSG 66295

 - hormone receptor assay

 - breast HRA 66315

 - ovary HRO 66315

- human placental lactogen

HPL 66301

- hydroxyprogesterone

OHP 66301

- insulin

INS 66301

- insulin, hypoglycaemia test

INHY 66297

- luteinizing hormone

LH 66301

- oestradiol

E2 66301

- oestriol

E3 66301

- oestrone

E1 66301

- parathyroid hormone

PTH 66301

- pentagastrin

PSTR 66297

SCHEDULE—continued

 - progesterone

PROG 66301

- prolactin

PROL 66301

- renin

REN 66301

- sex hormone binding globulin

SHBG 66301

- somatomedin

SOMA 66301

- testosterone

TES 66301

 - thyroid stimulating hormone

 

(where not

 requested as part of TFTs) TSH 66301

- urine steroid fraction or fractions

USF 66301

- vasoactive intestinal peptide

VIP 66301

- vasopressin

ADH 66301

- 11 deoxycortisol

DCOR 66301

Huhner's test HT 73521

Human placental lactogen HPL 66301

HVA (homovanillic acid) HVA 66281

Hydroxy methoxy phenylethylene glycol HMPG 66281

Hydroxy-3-methoxymandelic acid (previously 

known as VMA)

HMMA 66281

Hydroxychloroquine HOCQ 66235

Hydroxyindoleacetic acid HIAA 66273

Hydroxyprogesterone OHP 66301

Hydroxyproline HYDP 66273

Imipramine IMIP 66235

- imediate frozen section diagnosis of biopsy material

FS 72803

Immunoglobulins

- A

IGA 71067

- D

IGD 71067

- E (total)

IGE 71075-77

- G

IGG 71067

- G, 4 subclasses

SIGG 71073

- M

IGM 71067

Immunohistochemical investigation of biopsy material IHIS 72805

Insulin INS 66301

Insulin, hypoglycaemia test INHY 66297

Intestinal disaccharidases INTD 66285

Iron (see Iron studies)

Iron studies (iron, transferrin & ferritin) IS 66263

L-dopa GHLD 66295

Lactate LACT 66273

- dehydrogenase

LDH 66201

- dehydrogenase isoenzymes

LDI 66245

Lamellar body phospholipid LBPH 66243

Lead PB 66279

Lecithin/sphingomyelin ratio (amniotic fluid) LS 66243

SCHEDULE—continued

 

Leucocyte

- count

WCC 65001

 - 3 surface markers

 - blood, CSF, serous fluid LMH3 71139

 - tissue LMT3 71141

 - 6 surface markers

 - blood, CSF, serous fluid or tissue LM6 71143

 - blood, CSF, serous fluid & tissue (s) LMHT 71145

Lignocaine LIGN 66235

Lipoprotein electrophoresis LEPG 66245

Lipase LIP 66201

Lithium LI 66201

Lupus anticoagulant LUPA 65037

Luteinizing hormone LH 66301

Lymphocytes

 - functional tests

 - 1 estimation LF1 71127

 - 2 estimations LF2 71129

 - 3 estimations LF3 71131

Magnesium MG 66201

Mammary serum antigen MSA 66261

Manganese MN 66277

Mantoux test MANT 73811

Melanogen (see Urine melanin) UML 66213

Mercury HG 66277

Metalbumin detection (Schumm's test) SCHM 65027

Metadrenalines MNEP 66281

Methadone MTDN 66235

Methotrexate MTTA 66235

Methsuximide MSUX 66235

Metronidazole MRDZ 66235

Mexiletine (Mexitil) MEX 66235

Mianserin MIAS 66235

Microalbumin MALB 66259

Microbial antibody testing  

- actinomycetes

ACT 69229

- adenovirus

ADE 69229

- aspergillus

ASP 69229

- avian precipitins (bird fancier's disease)

APP 69229

- Blastomyces

BLM 69229

- Bordetella pertussis

BOR 69229

- Borrelia burgdorferi

BOB 69229

- Brucella

BRU 69229

- Campylobacter jejuni

CAM 69229

SCHEDULE—continued

 - Candida

CAN 69229

- Chlamydia

CHL 69229

- Coccidioides

CCC 69229

- Coxsackie B1-6

COX 69229

- cryptococus

CRY 69229

- cytomegalovirus

CMV 69229

- cytomegalovirus serology in pregnancy

CMVP 69253-57

- dengue

DEN 69229

- diphtheria

DIP 69229

- echinococcus

ECC 69299

- echo-coxsackie group

ECH 69229

- Entamoeba histolytica

AMO 69229

- Epstein Barr virus

EBV 69229

 - fluorescent treponemal antibody

  absorption test (FTA-ABS) FTA 69229

- Haemophilus influenzae

HUS 69229

- hepatitis delta antibody - anti-delta

HDA 69229

- herpes

HPA 69229

- Histoplasma

HIP 69229

- hydatid

HYD 69229

- influenza A

FLA 69229

- influenza B

FLB 69229

- Legionella pneumophila - serogroup 1

LP1 69229

- Legionella pneumophila - serogroup 2

LP2 69229

- leishmaniasis

LEI 69229

- Leptospira

LEP 69229

- Listeria

LIS 69229

- measles

MEA 69229

- Micropolyspora faeni

MIC 69229

- mumps

MUM 69229

- Murray Valley encephalitis

MVE 69229

- Mycoplasma pneumoniae

MYC 69229

- Neisseria menigitidis

MEN 69229

- Newcastle disease

NCD 69229

- parainfluenza 1

PF1 69229

- parainfluenza 2

PF2 69229

- parainfluenza 3

PF3 69229

- paratyphi

PTY 69229

- pertussis

PER 69229

- poliomyelitis

PLO 69229

- Proteus OX 19

POX 69229

- Proteus OXK

POK 69229

- Q fever

QFF 69229

- rapid plasma reagin test

RPR 69229

SCHEDULE—continued

 - respiratory syncytial virus

RSV 69229

- Ross River virus

RRV 69229

- rubella

RUB 69229

- Salmonella typhi (H)

SAH 69229

- Salmonella typhi (O)

SAO 69229

- Schistosoma

STO 69229

- streptococcal serology - anti-

  DNASE B titre ADNB 69229

- streptococcal serology-anti-streptolysin O titre

ASOT 69229

- Streptococcus pneumoniae

PCC 69229

- tetanus

TET 69229

- Thermoactinomyces vulgaris

THE 69229

- thermopolyspora

TPS 69229

- Toxocara

TOC 69229

- toxoplasma

TOX 69229

- TPHA(Treponema pallidum haemagglutin.test)

TPHA 69229

- Treponema pallidum haemagglutination test

TPHA 69229

- trichinosis

TOS 69229

- typhus, Weil-Felix

TYP 69229

- Varicella zoster

VCZ 69229

- VDRL (Venereal Disease Research Laboratory)

VDRL 69229

- Yersinia enterocolitica

YER 69229

Microbial antigen testing

- Chlamydia

CHLY 69221

- Clostridium difficile

CLDT 69219

- cryptococcal antigen

CRYN 69219

- group B streptococcus

STB 69219

- Haemophilus influenzae

HI 69219

- herpes simplex virus

HSV 69223

- Neisseria gonorrhoeae

GON 69219

- Neisseria meningitidis

NMG 69219

- respiratory syncytial virus

RSVN 69219

- Streptococcus pneumoniae

SPN 66219

- Varicella zoster

VCZN 69219

Micropolyspora faeni MIC 69229

Microscopic examination of: 

- faeces for parasites

OCP 69203

- material other than blood

M 69201

Microscopy & culture of:

- material from nose, throat, eye or ear

MCS1 69205

 - material from skin, superficial sites,

  urethra, vagina, cervix or rectum MCS2 69207

 - post-op wounds, aspirations of body

  cavities, synovial fluid, CSF  

SCHEDULE—continued

 

   & op/biopsy specimens  MCS3 69209

- specimens of sputum

MCS2 69207

 - specimens of sputum, urine

   or other body fluids for mycobacteria AFB 69213

Mucin-like carcinoma associated antigen MCA 66261

Mycobacteria microscopy & culture of sputum AFB 69213

N-acetyl procainamide NAPC 66235

Neisseria meningitidis antigens NMG 69219

Neural tube defects/Down syndrome NTDD 66321

Neuron-specific enolase NSEN 66261

Neutrophil functions NFT 71135

Nickel NI 66277

Nitrazepam NITR 66235

Nordothiepin NDIP 66235

Norfluoxetine NFLE 66235

Nortriptyline NORT 66235

Oestradiol E2 66301

Oestriol E3 66301

- for Down syndrome testing

NTDD 66321

Oestrone E1 66301

Oligoclonal proteins OGP 71065

Osmolality, serum or urine OSML 66223

Oxalate OXAL 66273

Oxazepam OXAZ 66235

PAA (phenyl acetic acid) PAA 66281

Palmitic acid in amniotic fluid PALM 66243

Paracetamol PARA 66235

Paraprotein investigation

  - by electrophoresis

EPPI 66245

- by immunoelectrophoresis or immunofixation

PPRO 71061

- on concurrently collected serum or urine

PPSU 71063

Paraquat PARQ 66235

Parathyroid hormone (PTH) PTH 66301

Partial thromboplastin time PTT 65029

Passovy factor PF 65045

Patient episode initiation fees PEI 73901-15

Pentobarbitone PENT 66235

Pentagastrin PSTR 66297

Perhexiline PHEX 66235

pH measurement of body fluids other than urine PH 66213

Phenobarbitone PHBA 66235

Phensuximide PHEN 66235

Phenylacetic acid PAA 66281

Phenytoin PHEY 66235

SCHEDULE—continued

 

Phosphate PHOS 66201

Phosphatidylglycerol PTGL 66243

Plasminogen PLAS 65037

Platelet

- aggregation

PLTG 65041

- count

PLTC 65001

Porphyrins (quantitative test, 1 or more 

fractions)

PR 66281

Potassium K 66201

Prealbumin PALB 66259

Prednisolone PRED 66235

Pregnancy serology

- 1 estimation

MSP1 69253

- 2 estimations

MSP2 69255

- 3 estimations

MSP3 69257

- for Down syndrome testing

NTDD 66321

Primidone PRIM 66235

Procainamide PCAM 66235

Progesterone PROG 66301

Prolactin PROL 66301

Prominal PROM 66235

Propranolol PPNO 66235

Prostate specific antigen PSA 66259

Prostatic acid phosphatase ACP 66259

Protein

- C

PROC 65037

- S

PROS 65037

 - quantitative estim. of specific protein

 - alpha fetoprotein AFP 66259

     - for Down syndrome testing NTDD 66321

 - alpha-l-antitrypsin AAT 66255

 - alpha-2-macroglobulin AMAC 66255

 - beta-2-microglobulin BMIC 66259

 - C-l esterase inhibitor CEI 66257

 - caeruloplasmin CPLS 66259

 - classes by electrophoresis EPPI 66245

 - ferritin (see also Iron studies)  FERR 66259

 - haptoglobins HGLB 66259

 - microalbumin  MALB 66259

 - transferrin (see also Iron studies) TRAN 66259

- total

PROT 66201

Prothrombin time  PT 65029

Pyruvate PVTE 66273

Quinalbarb QUIB 66235

SCHEDULE—continued

 

Quinidine QUIN 66235

Quinine QNN 66235

RAST RAST 71079

Red cell folate & serum B12 & serum folate if required RCF 66267

Red cell porphyrins - qualitative test RCP 65027

Renin REN 66301

Respiratory syncytial virus antigens RSVN 69219

Reticulocyte count RETC 65001

Rheumatoid factor RF 71105

- factor quantitation

RFQ 71107

RSV- respiratory syncytial virus RSVN 69219

Rubella serology RUB 69229

Salicylate - aspirin SALI 66235

Secretin SSGR 66297

Selenium SE 66277

Semen examination SEE 73523

- for spermatozoa (post vasectomy)

SES 73521

Serotonin 5HT 66273

Serology - in pregnancy (see Pregnancy serology)

Serum

- Bl2

B12 66265

- folate (with Bl2)

FOL 66265

- folate (with Bl2 red cell folate)

RCF 66267

Sex hormone binding globulin SHBG 66301

Snake venom HISS 66231

Sodium NA 66201

Solid tissue or tissues - chemical assays ENZS 66285

Somatomedin SOMA 66301

Sotalol SALL 66235

Specific IgG or IgE antibodies RAST 71079

Sperm antibodies SAB 73525

- penetrating ability

SPA 73525

Stelazine STEL 66235

Streptococcus pneumoniae antigens SPN 69219

Strontium SR 66277

Sulthiame (Ospolot) SUL 66235

Synacthen stimulation test SYNS 66297

Syphilis serology STS 69231

Testosterone TES 66301

Thalassaemia studies TS 65011

Theophylline THEO 66235

Thiopentone TOPO 66235

Thioridazine THIO 66235

Thrombin time TT 65029

SCHEDULE—continued

 

Thyroglobulin TGL 66261

Thyroid

- function tests

TFT 66291

- stimulating hormone

TSH 66301

Thyrotrophin releasing hormone test TRH 66293

Total free fatty acids TFFA 66273

Transferrin (see also Iron studies) TRAN 66259

Triglycerides TRIG 66201

Trimipramine TRIM 66235

TSH (where not requested as part of a thyroid function test) TSH 66301

Tumour markers

- CA-15.3 antigen

CA15 66261

- CA-19.9 antigen

CA19 66261

- CA-125 antigen

C125 66261

- carcinoembryonic antigen

CEA 66261

- mammary serum antigen

MSA 66261

- mucin-like carcinoma associated antigen

MCA 66261

- neuron specific enolase

NSEN 66261

- prostate specific antigen

PSA 66259

- prostatic acid phosphatase-1 or more fractions

ACP 66259

- thyroglobulin

TGL 66261

Tryptic activity in faeces TAF 66323

Urate URAT 66201

Urea U 66201

Urine

- bilirubin

UBIL 66213

- cystine (cysteine)

UCYS 66213

- haemoglobin

UHB 66213

- melanin (melanogen)

UML 66213

- microscopy, culture, identification & sensitivity

UMCS 69217

- myoglobin

UMY 66213

- porphobilinogen

UPG 66213

- porphyrins (qualitative test)

UPR 66213

- steroid fraction or fractions

USF 66301

- urobilinogen

UUB 66213

Valproate (Epilim) VALP 66235

Vancomycin VAN 66235

Varicella zoster antigens VCZN 69219

Vasoactive intestinal peptide VIP 66301

Vasopressin ADH 66301

Viscosity of blood or plasma VISC 65001

Vitamins 

- B12

RCF 66267

- D

VITD 66271

SCHEDULE—continued

 - folate

RCF 66267

- quantitative estimation of A, B1, B2, B3, B6, C or E

VIT 66269

VMA (see HMMA)

Von Willebrands factor VWF 65045

Von Willebrands factor antigen VWA 65045

Warfarin WFR 66235

Xylose XYL 66273

Zinc ZN 66273

    

____________________________________________________________________

NOTE

1. Notified in the Commonwealth of Australia Gazette on 27 October 1992.